These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 30070286)
1. Synthesis and biological evaluation of cyclic derivatives of combretastatin A-4 containing group 14 elements. Blasco V; Murga J; Falomir E; Carda M; Royo S; Cuñat AC; Sanz-Cervera JF; Marco JA Org Biomol Chem; 2018 Aug; 16(32):5859-5870. PubMed ID: 30070286 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of Combretastatin A-4 and 3'-Aminocombretastatin A-4 derivatives with Aminoacid Containing Pendants and Study of Their Interaction with Tubulin and as Downregulators of the VEGF, hTERT and c-Myc Gene Expression. Agut R; Falomir E; Murga J; Martín-Beltrán C; Gil-Edo R; Pla A; Carda M; Marco JA Molecules; 2020 Feb; 25(3):. PubMed ID: 32033084 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents. Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of thiophene and benzo[b]thiophene analogs of combretastatin A-4 and isocombretastatin A-4: A comparison between the linkage positions of the 3,4,5-trimethoxystyrene unit. Do CV; Faouzi A; Barette C; Farce A; Fauvarque MO; Colomb E; Catry L; Berthier-Vergnes O; Haftek M; Barret R; Lomberget T Bioorg Med Chem Lett; 2016 Jan; 26(1):174-80. PubMed ID: 26602281 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4. Guan Q; Yang F; Guo D; Xu J; Jiang M; Liu C; Bao K; Wu Y; Zhang W Eur J Med Chem; 2014 Nov; 87():1-9. PubMed ID: 25233100 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation as antiangiogenic agents of ureas derived from 3'-aminocombretastatin A-4. Conesa-Milián L; Falomir E; Murga J; Carda M; Marco JA Eur J Med Chem; 2019 Jan; 162():781-792. PubMed ID: 30502686 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of benzils related to combretastatin A-4. Mousset C; Giraud A; Provot O; Hamze A; Bignon J; Liu JM; Thoret S; Dubois J; Brion JD; Alami M Bioorg Med Chem Lett; 2008 Jun; 18(11):3266-71. PubMed ID: 18477509 [TBL] [Abstract][Full Text] [Related]
9. Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects. Barrett I; Carr M; O'Boyle N; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ J Enzyme Inhib Med Chem; 2010 Apr; 25(2):180-94. PubMed ID: 20222762 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents. Wu M; Sun Q; Yang C; Chen D; Ding J; Chen Y; Lin L; Xie Y Bioorg Med Chem Lett; 2007 Feb; 17(4):869-73. PubMed ID: 17174089 [TBL] [Abstract][Full Text] [Related]
11. 3-(3,4,5-Trimethoxyphenylselenyl)-1H-indoles and their selenoxides as combretastatin A-4 analogs: microwave-assisted synthesis and biological evaluation. Wen Z; Xu J; Wang Z; Qi H; Xu Q; Bai Z; Zhang Q; Bao K; Wu Y; Zhang W Eur J Med Chem; 2015 Jan; 90():184-94. PubMed ID: 25461319 [TBL] [Abstract][Full Text] [Related]
12. 4,5-Diaryl-3-aminopyrazole derivatives as analogs of Combretastatin A-4: synthesis and biological evaluation. Liu T; Cui R; Chen J; Zhang J; He Q; Yang B; Hu Y Arch Pharm (Weinheim); 2011 May; 344(5):279-86. PubMed ID: 21290430 [TBL] [Abstract][Full Text] [Related]
13. Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers. Lawrence NJ; Rennison D; Woo M; McGown AT; Hadfield JA Bioorg Med Chem Lett; 2001 Jan; 11(1):51-4. PubMed ID: 11140732 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4. Hall JJ; Sriram M; Strecker TE; Tidmore JK; Jelinek CJ; Kumar GD; Hadimani MB; Pettit GR; Chaplin DJ; Trawick ML; Pinney KG Bioorg Med Chem Lett; 2008 Sep; 18(18):5146-9. PubMed ID: 18710804 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416. Pandit B; Sun Y; Chen P; Sackett DL; Hu Z; Rich W; Li C; Lewis A; Schaefer K; Li PK Bioorg Med Chem; 2006 Oct; 14(19):6492-501. PubMed ID: 16860559 [TBL] [Abstract][Full Text] [Related]
16. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects. Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation, and structure-activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitors. Aziz J; Brachet E; Hamze A; Peyrat JF; Bernadat G; Morvan E; Bignon J; Wdzieczak-Bakala J; Desravines D; Dubois J; Tueni M; Yassine A; Brion JD; Alami M Org Biomol Chem; 2013 Jan; 11(3):430-42. PubMed ID: 23047722 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic evaluation of N-(4-methoxy-1H-benzo[d]imidazol-7-yl)-arylsulfonamide and N-aryl-(4-methoxy-1H-benzo[d]imidazol)-7-sulfonamide analogs of combretastatin A-4. Zhou J; Zhang Y; Cui YW; Li ZM; Song HR; Dong JH; Chen XG; Xu BL J Asian Nat Prod Res; 2011 Apr; 13(4):330-40. PubMed ID: 21462036 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted isocombretastatin A-4 analogs. Rasolofonjatovo E; Provot O; Hamze A; Rodrigo J; Bignon J; Wdzieczak-Bakala J; Lenoir C; Desravines D; Dubois J; Brion JD; Alami M Eur J Med Chem; 2013 Apr; 62():28-39. PubMed ID: 23353744 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents. Conesa-Milián L; Falomir E; Murga J; Carda M; Meyen E; Liekens S; Alberto Marco J Eur J Med Chem; 2018 Mar; 147():183-193. PubMed ID: 29432949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]